Literature DB >> 17373964

Glucose transporter expression on the plasma membrane of resting and activated white blood cells.

E Maratou1, G Dimitriadis, A Kollias, E Boutati, V Lambadiari, P Mitrou, S A Raptis.   

Abstract

BACKGROUND: In white blood cells (WBC), the increase in glucose utilization is a prominent feature during immune response and this depends on the function of specific glucose transporter (GLUT) isoforms. The objective was to examine the effects of activation by Phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS) and insulin on the expression of GLUT isoforms in all subpopulations of WBC.
MATERIALS AND METHODS: Blood was withdrawn from 27 healthy subjects. The expression of GLUT1, GLUT3 and GLUT4 on the plasma membrane of resting and activated monocytes, T- and B-lymphocytes and polymorphonuclear cells (PMNs) was determined in the absence and presence of physiological concentrations of insulin, by flow cytometry.
RESULTS: GLUT1 did not respond to insulin in either resting or PMA/LPS activated state. In the resting state, monocytes and B-lymphocytes increased the abundance of GLUT3 and GLUT4 on their plasma membrane in response to insulin; in contrast, T-lymphocytes and PMNs were unresponsive to insulin. In the activated state, monocytes, B- and T- lymphocytes increased the expression of all three GLUT isoforms on their plasma membrane, whilst PMNs increased only GLUT1 and GLUT3; in all WBC, insulin augmented the expression of GLUT4 and GLUT3 isoforms in addition to the stimulation provided by the PMA or LPS treatment alone.
CONCLUSION: Activation of WBC leads to increased expression of GLUT1, GLUT3 and GLUT4 isoforms on their plasma membrane; this process was further augmented by insulin. During infection, these mechanisms may help to redistribute glucose as a potential source of energy away from peripheral tissues and direct it towards cells that mediate the immune response and are therefore crucial to survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373964     DOI: 10.1111/j.1365-2362.2007.01786.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  70 in total

1.  Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.

Authors:  Chetan V Jawale; Kritika Ramani; De-Dong Li; Bianca M Coleman; Rohan S Oberoi; Saran Kupul; Li Lin; Jigar V Desai; Greg M Delgoffe; Michail S Lionakis; Filitsa H Bender; Alexander J Prokopienko; Thomas D Nolin; Sarah L Gaffen; Partha S Biswas
Journal:  Sci Transl Med       Date:  2020-06-17       Impact factor: 17.956

2.  Glucose transporter-4 in white blood cells of young and old sled dogs: a model for human biomarker development.

Authors:  Theresia M Schnurr; Arleigh J Reynolds; Lawrence K Duffy; Kriya L Dunlap
Journal:  Polar Rec (Gr Brit)       Date:  2013-11-28       Impact factor: 0.658

3.  The host response to poly(lactide-co-glycolide) scaffolds protects mice from diet induced obesity and glucose intolerance.

Authors:  Michael A Hendley; Kendall P Murphy; Christopher Isely; Heather L Struckman; Prakasam Annamalai; R Michael Gower
Journal:  Biomaterials       Date:  2019-06-19       Impact factor: 12.479

4.  Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner.

Authors:  Sean D Kelly; Constance S Harrell; Gretchen N Neigh
Journal:  Physiol Behav       Date:  2013-12-29

Review 5.  The facilitative glucose transporter GLUT3: 20 years of distinction.

Authors:  Ian A Simpson; Donard Dwyer; Daniela Malide; Kelle H Moley; Alexander Travis; Susan J Vannucci
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

6.  In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.

Authors:  Rama K Mishra; Changyong Wei; Richard C Hresko; Richa Bajpai; Monique Heitmeier; Shannon M Matulis; Ajay K Nooka; Steven T Rosen; Paul W Hruz; Gary E Schiltz; Mala Shanmugam
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

7.  FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future.

Authors:  Abass Alavi; Thomas J Werner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03       Impact factor: 9.236

Review 8.  Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Authors:  Sophie M Poznanski; Nicole G Barra; Ali A Ashkar; Jonathan D Schertzer
Journal:  Inflamm Res       Date:  2018-07-31       Impact factor: 4.575

9.  Exercise Increases Glucose Transporter-4 Levels on Peripheral Blood Mononuclear Cells.

Authors:  Kendra D Sticka; Theresia M Schnurr; Scott P Jerome; Andres Dajles; Arleigh J Reynolds; Lawrence K Duffy; Cindy M Knall; Kriya L Dunlap
Journal:  Med Sci Sports Exerc       Date:  2018-05       Impact factor: 5.411

10.  Insulin effect on glucose transport in thymocytes and splenocytes from rats with metabolic syndrome.

Authors:  Roxana Carbó; Verónica Guarner
Journal:  Diabetol Metab Syndr       Date:  2010-11-02       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.